Asset Management One’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Asset Management One’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,231	Closed	-$884K	–	1071
2020 Q4	$884K	Sell	10,231 -14,965	-59%	-$1.27M	﹤0.01%	869
2020 Q3	$1.64M	Hold	25,196	–	–	0.01%	789
2020 Q2	$1.84M	Hold	25,196	–	–	0.01%	771
2020 Q1	$857K	Sell	25,196 -30,238	-55%	-$1.38M	0.01%	830
2019 Q4	$3.02M	Hold	55,434	–	–	0.01%	741
2019 Q3	$2.31M	Buy	55,434 +19,527	+54%	+$825K	0.01%	774
2019 Q2	$1.57M	Buy	+35,907	New	+$2.02M	0.01%	837

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Asset Management One's BHVN Position: Q1 2021 in Review

Asset Management One sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2021, closing a stake of 10,231 shares — an estimated $884K sold.

Asset Management One first reported a position in BHVN in Q2 2019 and held it in 7 quarters. The position peaked at $3.02M in Q4 2019. 224 funds tracked by Wall St. Rank hold BHVN as of Q1 2021.

Asset Management One reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2021 after selling out during the quarter.
Asset Management One sold 10,231 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2021, an estimated $884K.
Asset Management One first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 7 quarters.
Asset Management One's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.02M in Q4 2019.
224 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2021.

Based on Asset Management One's 13F filing for Q1 2021, filed 14 May 2021.